Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients.
作者信息
Molmenti E P, Nagata D, Roden J, Squires R, Molmenti H, Casey D, Fasola C, Lopez M J, Winick N, McPhail W, D'Amico L, Goldstein R, Levy M, Fasola C, Andersen J, Klintmalm G
机构信息
Baylor University Medical Center, Children's Medical Center of Dallas, Dallas, Texas, USA.
出版信息
Transplant Proc. 2001 Feb-Mar;33(1-2):1727. doi: 10.1016/s0041-1345(00)02824-4.
Abstract
摘要
相似文献
1
Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients.小儿肝移植受者移植后淋巴细胞增生性疾病的发病率、管理及结局
Transplant Proc. 2001 Feb-Mar;33(1-2):1727. doi: 10.1016/s0041-1345(00)02824-4.
2
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.接受他克莫司（FK506）初始治疗的小儿肝移植受者的移植后淋巴细胞增生性疾病的管理
Transplantation. 1998 Oct 27;66(8):1047-52. doi: 10.1097/00007890-199810270-00014.
3
Thirteen years' experience in pediatric liver transplantation: differences between tacrolimus and cyclosporine.
Transplant Proc. 2002 Aug;34(5):1976-8. doi: 10.1016/s0041-1345(02)03147-0.
4
Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.接受他克莫司治疗的小儿肝移植受者中，与爱泼斯坦-巴尔病毒相关的移植后淋巴细胞增生性疾病发病率增加的早期迹象和风险因素。
Transplantation. 1997 Nov 27;64(10):1438-42. doi: 10.1097/00007890-199711270-00011.
5
Posttransplant lymphoproliferative disorder after liver and kidney transplant.肝肾移植后移植后淋巴细胞增生性疾病
Exp Clin Transplant. 2014 Mar;12 Suppl 1:142-8.
6
Low incidence of posttransplant lymphoproliferative disease in children treated with low-dose immunosuppression after liver transplantation.
Transplant Proc. 2002 Aug;34(5):1961-2. doi: 10.1016/s0041-1345(02)03139-1.
7
Neoral is superior to FK 506 in liver transplantation.
Transplant Proc. 1998 Aug;30(5):1812-5. doi: 10.1016/s0041-1345(98)00442-4.
8
The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.免疫抑制对小儿肝移植患者移植后淋巴细胞增生性疾病的影响。
Transplantation. 2000 Jul 15;70(1):94-9.
9
Monitoring of Epstein-Barr virus serology in children after liver transplant: lack of clinical correlation.
Transplant Proc. 2000 Jun;32(4):706-7. doi: 10.1016/s0041-1345(00)00949-0.
10
Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.肝移植后移植后淋巴组织增生性疾病：发病率、长期生存率及血清他克莫司水平的影响
World J Gastroenterol. 2017 Feb 21;23(7):1224-1232. doi: 10.3748/wjg.v23.i7.1224.
Zotero 插件